argenx SE Results Presentation Deck
March 2021, 20 slides
  1. argenx SE
  2. Related Decks
  3. Results Presentation Decks
together we discover a | argenx SE
forward looking statements plena | argenx SE
year for | argenx SE
biology is foundational to the immune system | argenx SE
first in class antagonist patients on drug for more than years | argenx SE
promising value proposition to patients oes | argenx SE
bridging strategy leverages correlation between pharmacodynamic and clinical effect ado myasthenia | argenx SE
chronic inflammatory polyneuropathy phase adhere trial | argenx SE
phase advance two trials run in parallel it primary weeks determined at | argenx SE
phase trial in pemphigus focus on potential to drive fast onset and steroid sparing address | argenx SE
broad pipeline opportunity | argenx SE
broad opportunity by targeting phase healthy volunteer data expected mid phase indications and formulations unique intervention | argenx SE
strategy | argenx SE
immunology innovation program i discovery | argenx SE
full year financial results | argenx SE
listening to and learning from community fried | argenx SE
regulatory update united states global launched approval access program in the united states and of | argenx SE
preparing for a successful launch physician education payor engagement building the team manufacturing commitment patients | argenx SE
is just the beginning adept | argenx SE
building tomorrow immunology company strategic priorities | argenx SE
See More
argenx SE
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Autoimmune
Recent decks by argenx SE
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
See all presentations by argenx SE (28 decks)
Related decks
Immix Biopharma
Investor Presentation
March 2024
Cabaletta Bio
Investor Presentation
October 2022
AbCellera
Investor Conference
January 2024
Roivant Sciences
Investor Presentation
September 2022
Compass Therapeutics
IPO
November 2020
Recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
March 2024
Cabaletta Bio
Investor Presentation
October 2022
AbCellera
Investor Conference
January 2024
Roivant Sciences
Investor Presentation
September 2022
Compass Therapeutics
IPO
November 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights